Clinical Trials Directory

Trials / Completed

CompletedNCT02834325

Predicting Success of HFNC: The Utility of the ROX Index

Predicting Failure of High Flow Nasal Cannula in Pneumonia Patients With Hypoxemic Respiratory Failure: The Utility of ROX Index

Status
Completed
Phase
Study type
Observational
Enrollment
201 (actual)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study was to describe early predictors and to develop a prediction tool that accurately identifies the need for mechanical ventilation in pneumonia patients with acute respiratory failure treated with High Flow nasal cannula.

Detailed description

Purpose The purpose of the study is to describe early predictors and to develop a prediction tool that accurately identifies the need for mechanical ventilation (MV) in pneumonia patients with hypoxemic acute respiratory failure (ARF) treated with high-flow nasal cannula (HFNC). Materials and methods This is a 4-year prospective observational 2-center cohort study including patients with severe pneumonia treated with HFNC. High-flow nasal cannula failure was defined as need for MV. ROX index was defined as the ratio of pulse oximetry/fraction of inspired oxygen to respiratory rate.

Conditions

Interventions

TypeNameDescription
PROCEDUREmechanical ventilation

Timeline

Start date
2009-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2016-07-15
Last updated
2016-07-15

Source: ClinicalTrials.gov record NCT02834325. Inclusion in this directory is not an endorsement.